Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fluorocyclopentenylcytosine

Known as: 4-Amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1H)-one 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
RX-3117 is a novel cytidine analog showing encouraging results in ongoing Phase 2a studies with gemcitabine-resistant pancreatic… Expand
2018
2018
Abstract DNA methylation plays an important role in carcinogenesis and aberrant methylation patterns have been found in many… Expand
2016
2016
Fluorocyclopentenylcytosine (RX-3117) is an orally available cytidine analog, currently in Phase I clinical trial. RX-3117 has… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
ABSTRACT Antimetabolites are incorporated into DNA and RNA, affecting their function. Liquid-chromatography-mass-spectrometry (LC… Expand
2015
2015
Fluorocyclopentenylcytosine (RX-3117) is an orally bioavailable novel cytidine analog, currently being tested in a Phase I… Expand
Review
2014
Review
2014
  • G. Peters
  • Nucleosides, nucleotides & nucleic acids
  • 2014
  • Corpus ID: 205855349
Antimetabolites are the most widely used and most efficacious group of anticancer drugs. Antimetabolites are also the oldest… Expand
2014
2014
RX-3117 (fluorocyclopentenylcytosine) is a cytidine analog and this class of drugs, including gemcitabine, has been widely used… Expand
2013
2013
SummaryA novel cytidine analog fluorocyclopentenylcytosine (RX-3117; TV-1360) was characterized for its cytotoxicity in a 59-cell… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2